Pharmalot… Pharmalittle… Good Morning

Good morning, folks, and how are you today? A spot of rain is falling on the Pharmalot corporate campus, where we are doing our best to energize the short people and tend to the usual early-in-the-day to-do list. Of course, the middle of the week only intensifies the need to move quickly. We trust you relate. So join us as we grab another cup of stimulation and dig in for another busy day. As always, here are some items of interest to help you along. Hope your day is smashing and do stay in touch… FDA OKs Pill For Post-Menopausal Sex Problems (Los Angeles Times) Allergan Settles Oklahoma Botox Case During Trial (Bloomberg News) Hospira Issues Another Recall (Outsourcing Pharma) Former AstraZeneca Employee Arrested For Bilking Drugmaker (News-Journal) Biosimilars Will Take Awhile To Get Here (Wall Street Journal) China To Announce Reforms To Regulatory Process (Regulatory Focus) FDA Delays Approval Of Zogenix Painkiller (Bloomberg News) Vertex Readies Late-Stage Cystic Fibrosis Studies (TheStreet) Another Study Links Glaxo Flu Shot To Narcolepsy (Reuters) Elan Unimpressed With $6.5 Billion Takeover Bid (Pharma Times) Merck’s Tredaptive Raises Risk Of Muscle Pain In Study (Bloomberg News) EDITOR’S NOTE: Please check this post for additional items during the day rain pic thx to sterlic on flickr
Source: Pharmalot - Category: Pharma Commentators Authors: Tags: Uncategorized Allergan AstraZeneca Biosimilars Botox Cystic Fibrosis Elan FDA Flu GlaxoSmithKline Hospira Influenza Menopause Merck Narcolepsy Osphena Pandemrix Royalty Pharma SFDA Shionogi Tredaptive Vertex Pharm Source Type: blogs